logo
PAVmed subsidiary Veris Health partners with Ohio State University cancer center

PAVmed subsidiary Veris Health partners with Ohio State University cancer center

Yahoo04-06-2025
PAVmed's (PAVM) majority-owned digital health subsidiary Veris Health has entered into a strategic partnership agreement with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, or OSUCCC – James, a National Cancer Institute-Designated Comprehensive Cancer Center. This agreement follows the successful completion of a pilot program which enrolled patients across several OSUCCC – James cancer care service lines on the Veris Cancer Care Platform. Veris and OSUCCC – James entered into a long-term, multi-project strategic partnership to utilize, and further the development and commercialization of the Veris Cancer Care Platform and its implantable physiologic monitor. The agreement includes expansion of commercial utilization of the platform across cancer care service lines; full electronic health record integration; initiation of a clinical registry of patients enrolled on the platform to be launched in the coming weeks; and launch of a clinical trial of patients receiving the implantable physiologic monitor, to be launched upon FDA clearance, expected next year. Cancer patients enrolled on the platform receive a VerisBox of Veris-branded connected health care devices which transmit physiologic data to the cloud-based clinician portal via embedded cellular connections.
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PAVM:
Disclaimer & DisclosureReport an Issue
Lucid Diagnostics to join Russell 2000, Russell 3000 indexes
PAVmed's Earnings Call: Optimism Amid Challenges
PAVmed's Strategic Advancements and Growth Potential Drive Buy Rating
Pavmed Inc. Reports Turnaround with Strong Q1 Earnings
PAVmed Reports Q1 2025 Financial Results and Updates
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lucid Diagnostics to Participate in Upcoming Investor Conferences
Lucid Diagnostics to Participate in Upcoming Investor Conferences

Yahoo

time4 hours ago

  • Yahoo

Lucid Diagnostics to Participate in Upcoming Investor Conferences

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that management will participate in the following upcoming investor conferences: 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference 1x1 Meetings: August 11-12, 2025 Location: Virtual Canaccord Genuity 45th Annual Growth Conference Fireside Chat: August 13, 2025, at 2:30 PM ET Location: Boston, MA The live and archived webcast of the Canaccord Genuity fireside chat can be accessed by clicking here or by visiting the Investor Relations Section of the Lucid Diagnostics website. A replay of the webcast will be available on the website for 30 days following the conclusion of the live broadcast. About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. For more information, please visit and for more information about its parent company PAVmed, please visit View original content to download multimedia: SOURCE Lucid Diagnostics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Coca-Cola makes sweetener change. Is corn syrup or cane sugar healthier?
Coca-Cola makes sweetener change. Is corn syrup or cane sugar healthier?

Yahoo

time14 hours ago

  • Yahoo

Coca-Cola makes sweetener change. Is corn syrup or cane sugar healthier?

Coca-Cola will be adding cane sugar to its ingredients list after all. 'We're going to be bringing a Coke sweetened with US cane sugar into the market this fall, and I think that will be an enduring option for consumers,' Coca-Cola CEO James Quincey said on a second-quarter call with investors and analysts on July 22. The company initially declined to comment on its intentions to use cane sugar after President Donald Trump claimed it would do so in July. 'I have been speaking to Coca-Cola about using REAL Cane Sugar in Coke in the United States, and they have agreed to do so,' Trump wrote in a July 16 Truth Social post. 'I'd like to thank all of those in authority at Coca-Cola. This will be a very good move by them — You'll see. It's just better!' Coke didn't confirm the claim at the time, saying in a statement shared with USA TODAY that it would share details on new offerings soon and appreciated Trump's enthusiasm for its product. Rather than replace high-fructose corn syrup as the sweetener in its flagship line, however, the sugar will be used in a drink that 'complements' and 'expands' its product range, Quincey said in the earnings call and subsequent report. USA TODAY has reached out to Coca-Cola for comment. High-fructose corn syrup is one of the ingredients the Trump administration has pushed companies to remove from food and beverages as part of its 'Make America Healthy Again' initiative. But is cane sugar actually 'healthier' for you? Here's what to know. What is high-fructose corn syrup? High-fructose corn syrup is a viscous, sweet substance made from cornstarch. When broken down into individual molecules, it becomes corn syrup, virtually a 100% glucose product, according to the Food and Drug Administration (FDA). Enzymes are then added to make some of the glucose into fructose, another simple sugar that naturally occurs in fruits. The resulting product is higher in fructose compared to the pure glucose in plain corn syrup, hence the 'high' in the name. High-fructose corn syrup is used in a large number of processed and packaged foods. Because it is cheaper to produce and more shelf-stable than regular sugar, it is widely used in the food manufacturing industry, according to the Cleveland Clinic. What is cane sugar? Cane sugar is derived from the natural byproduct of sugarcane − a tall, perennial, tropical grass from which liquid is extracted to create sugar. Corn is in the same plant family as sugarcane, which allows for the extraction of sweetener from both. The way raw sugarcane is processed and refined determines the product it ultimately yields. It can be made into a syrup, juice or crystallized and refined further into products like white sugar, brown sugar, molasses or jaggery, according to the United States Department of Agriculture (USDA) and WebMD. Cane sugar consists of sucrose, which is one-half glucose and one-half fructose. Is cane sugar better for you than high-fructose corn syrup? Like all types of added sugar, both cane and high-fructose corn syrup can have negative health effects, like weight gain, diabetes and heart disease, if consumed in excess. The FDA says it is 'not aware of any evidence' of a difference in safety between foods containing high-fructose corn syrup and 'foods containing similar amounts of other nutritive sweeteners with approximately equal glucose and fructose content, such as sucrose, honey, or other traditional sweeteners.' Dr. Wesley McWhorter, spokesperson for the Academy of Nutrition and Dietetics, told USA TODAY that high intakes of any added sugar can cause health issues, but that our bodies break down some types differently. 'High fructose corn syrup and cane sugar are both forms of added sugar, and both contain glucose and fructose; cane sugar is sucrose, which is 50% fructose, while high fructose corn syrup typically contains about 55%,' he said. 'Your body processes them similarly, but fructose is primarily metabolized in the liver. When consumed in excess, especially from sugary drinks and other concentrated sources, fructose can promote fat accumulation in the liver, a key contributor to non-alcoholic fatty liver disease.' He hopes the conversation around Coke's change sparks a larger conversation about reducing the amount of added sugar Americans consume in general, regardless of the type. 'Long-term health isn't about swapping one sweetener for another; it's about making meaningful changes to cut added sugar and improve the overall quality of the foods we eat,' he said. This article originally appeared on USA TODAY: Cane sugar vs. high-fructose corn syrup: Which one is healthier?

IHCL to bring Taj hotel brand to Naina Tikker, India
IHCL to bring Taj hotel brand to Naina Tikker, India

Yahoo

time16 hours ago

  • Yahoo

IHCL to bring Taj hotel brand to Naina Tikker, India

Indian Hotels Company Limited (IHCL) has unveiled the signing of a new property in Naina Tikker, Himachal Pradesh, marking an expansion of its luxury portfolio in the region. The 120-key Taj-branded hotel, a brownfield project, will offer views of the Dhauladhar mountain range and cater to both leisure and business travellers. The upcoming hotel is set to feature an array of amenities, including a variety of dining options such as a speciality restaurant, an all-day dining restaurant, a bar, and a lobby lounge. Guests will also enjoy a 4,000ft² banquet hall, meeting rooms, and wellness facilities. IHCL has partnered with automotive component manufacturer Micro Turners Group for this project. Micro Turners Group spokespeople Sachin Kapoor and Sagarika Kapoor said: 'We are excited to partner with IHCL for another project and bring the iconic Taj brand to Naina Tikker. This collaboration will redefine luxury hospitality in the region and unlock the tourism potential of the state.' Located in Himachal Pradesh's Sirmaur district, Naina Tikker is known for its biodiversity and spiritual heritage. The region is also a sanctuary for bird enthusiasts, surrounded by grasslands and pine forests. IHCL real estate and development executive vice-president Suma Venkatesh said: 'Naina Tikker represents a unique opportunity for the Taj brand to mark its presence in a relatively unexplored part of Himachal Pradesh. 'With excellent connectivity and a location surrounded by a protected forest, it is poised to become a sought-after destination for leisure, MICE and social celebrations. This addition strengthens IHCL's presence in the region, enabling a travel circuit across Chandigarh, Chail, Theog, and Dehradun. We are delighted to further strengthen our partnership with Micro Turners Group.' With this new addition, IHCL's portfolio in Himachal Pradesh will include 13 hotels, with eight currently under development. Earlier in the year, IHCL broadened its presence in Himachal Pradesh with the signing of a new Gateway hotel in McLeodganj. "IHCL to bring Taj hotel brand to Naina Tikker, India" was originally created and published by Hotel Management Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store